Heptos contains ribavirin 200 mg capsules. Ribavirin combination with interferon alfa-2b (pegylated and non pegylated) is indicated for the treatment of Chronic Hepatitis C (CHC) in patients 3 years of age and older with compensated liver disease.

Heptos is administered according to body weight. Dose reduction or discontinuation is recommended in patients experiencing certain adverse reactions or renal dysfunction